000			02218 a2200613 4500
005			20250515171421.0
264		0	_c20090701
008			200907s 0 0 eng d
022			_a1527-3350
024	7		_a10.1002/hep.22877 _2doi
040			_aNLM _beng _cNLM
100	1		_aWelzel, Tania Mara
245	0	0	_aVariants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial. _h[electronic resource]
260			_bHepatology (Baltimore, Md.) _cJun 2009
300			_a1847-58 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
650	0	4	_aAntiviral Agents _xadministration & dosage
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aHepatitis C, Chronic _xcomplications
650	0	4	_aHumans
650	0	4	_aInterferon alpha-2
650	0	4	_aInterferon-alpha _xadministration & dosage
650	0	4	_aLiver Cirrhosis _xetiology
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPolyethylene Glycols _xadministration & dosage
650	0	4	_aPolymorphism, Genetic
650	0	4	_aRecombinant Proteins
650	0	4	_aRibavirin _xadministration & dosage
650	0	4	_aTime Factors
700	1		_aMorgan, Timothy R
700	1		_aBonkovsky, Herbert L
700	1		_aNaishadham, Deepa
700	1		_aPfeiffer, Ruth M
700	1		_aWright, Elizabeth C
700	1		_aHutchinson, Amy A
700	1		_aCrenshaw, Andrew T
700	1		_aBashirova, Arman
700	1		_aCarrington, Mary
700	1		_aDotrang, Myhanh
700	1		_aSterling, Richard K
700	1		_aLindsay, Karen L
700	1		_aFontana, Robert J
700	1		_aLee, William M
700	1		_aDi Bisceglie, Adrian M
700	1		_aGhany, Marc G
700	1		_aGretch, David R
700	1		_aChanock, Stephen J
700	1		_aChung, Raymond T
700	1		_aO'Brien, Thomas R
773	0		_tHepatology (Baltimore, Md.) _gvol. 49 _gno. 6 _gp. 1847-58
856	4	0	_uhttps://doi.org/10.1002/hep.22877 _zAvailable from publisher's website
999			_c18862526 _d18862526